Phathom Pharmaceuticals
Earnings Surprise
Analysts estimated PHAT earnings of $-0.39 per share this quarter (Q4). PHAT's actual earnings were $-0.29 per share.
PHAT EPS surprise of 25.47%Analysts estimated PHAT earnings of $-0.56 per share this quarter (Q3). PHAT's actual earnings were $-0.41 per share.
PHAT EPS surprise of 26.25%Analysts estimated PHAT earnings of $-1.06 per share this quarter (Q2). PHAT's actual earnings were $-0.79 per share.
PHAT EPS surprise of 25.53%Analysts estimated PHAT earnings of $-1.17 per share this quarter (Q1). PHAT's actual earnings were $-1.31 per share.
PHAT EPS surprise of -12.00%Analysts estimated PHAT earnings of $-1.30 per share this quarter (Q4). PHAT's actual earnings were $-1.05 per share.
PHAT EPS surprise of 19.05%Analysts estimated PHAT earnings of $-1.52 per share this quarter (Q3). PHAT's actual earnings were $-1.32 per share.
PHAT EPS surprise of 13.44%Analysts estimated PHAT earnings of $-1.41 per share this quarter (Q2). PHAT's actual earnings were $-1.56 per share.
PHAT EPS surprise of -10.83%Analysts estimated PHAT earnings of $-1.34 per share this quarter (Q1). PHAT's actual earnings were $-1.42 per share.
PHAT EPS surprise of -6.34%Analysts estimated PHAT earnings of $-1.10 per share this quarter (Q4). PHAT's actual earnings were $-0.80 per share.
PHAT EPS surprise of -27.17%Analysts estimated PHAT earnings of $-0.91 per share this quarter (Q3). PHAT's actual earnings were $-0.76 per share.
PHAT EPS surprise of -16.42%